Example: stock market
PRODUCT MONOGRAPH INCLUDING PATIENT …
imbalance (including hypokalaemia, hyponatraemia, hypochloraemia and hyperkalaemia) occurring in approximately 4% of the patients, followed by dizziness (including orthostatic hypotension and vertigo), fatigue occurring in approximately 3% of …
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
![[Product Monograph Template - Standard]](/cache/preview/b/5/6/4/6/9/f/8/thumb-b56469f81fe4cee7737b379eed8967bf.jpg)
[Product Monograph Template - Standard]
www.leo-pharma.cainnohep® (tinzaparin sodium) Product Monograph, version 7.0 Page 6 of 36 Post-Surgical Bleeding: As with all antithrombotic agents, there is a risk of systemic bleeding with INNOHEP. Care should be taken with INNOHEP use in high dose treatment of newly
Fucithalmic PM 1.01 20-AUG-2008 - LEO Pharma
www.leo-pharma.caLEO® FUCITHALMIC® (fusidic acid) Product Monograph, version 1.01 (2008.08.20) Page 5 of 28 Paediatric Use Quantitative bacteriology studies have not …
PRODUCT MONOGRAPH - Pr innohep®
www.leo-pharma.caMay 26, 2017 · The multi-dose vial contains sodium metabisulphite and benzyl alcohol. The 8,000 IU, 10,000 IU, 12,000 IU, 14,000 IU, 16,000 IU and 18,000 IU pre-filled syringes contain sodium metabisulfite . For a complete listing see Dosage …
Related documents
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.eisai.comLENVIMATM Product Monograph Page 1 of 52. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . PrLENVIMA. Lenvatinib capsules . 4mg and 10mg Lenvatinib (as lenvatinib mesylate) Multiple Receptor Tyrosine Kinase Inhibitor
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPage 1 of 40 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrNUCALA Mepolizumab for Injection 100 mg/mL lyophilized powder for subcutaneous injection
PRODUCT MONOGRAPH INCLUDING PATIENT …
ca.gsk.comPage 1 of 49 PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PrTRELEGY ELLIPTA fluticasone furoate/umeclidinium (as bromide)/vilanterol (as trifenatate), dry powder for oral
PRODUCT MONOGRAPH INCLUDING PATIENT …
labeling.cslbehring.caPage 1 of 24 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . HAEGARDA™. C1 Esterase Inhibitor Subcutaneous (Human) Lyophilised powder 2000 IU/vial, reconstituted with 4 mL of diluent
PRODUCT MONOGRAPH INCLUDING PATIENT …
pp.jazzpharma.comPRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION C XYREM® (sodium oxybate) Oral solution at 500 mg/mL CNS Depressant Jazz Pharmaceuticals Ireland Limited
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caADLYXINE - Product Monograph Page 1 of 79. PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . Pr ADLYXINE™ . lixisenatide injection . 0.05 mg per mL (10 μg/dose)
PRODUCT MONOGRAPH INCLUDING PATIENT …
products.sanofi.caPage 1 of 64. PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION . PrPRALUENT®. alirocumab . solution for subcutaneous injection . 75 mg/mL and 150 mg/mL
PRODUCT MONOGRAPH INCLUDING PATIENT …
purdue.caFOQUEST™ (methylphenidate hydrochloride CR capsules) Page 1 of 37 . PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION . FOQUEST™ methylphenidate hydrochloride
INCLUDING PATIENT MEDICATION …
purdue.caDilaudid® (hydromorphone HCl) Page 1 of 36. PRESCRIBING INFORMATION . INCLUDING PATIENT MEDICATION INFORMATION . NDILAUDID® (HYDROmorphone* hydrochloride) 1 mg, 2 mg, 4 mg and 8 mg Tablets . 2 mg/mL Sterile Solution for Injection
INCLUDING PATIENT MEDICATION …
hepcbc.cacirrhosis including 1035 patients who received EPCLUSA for 12 weeks. The proportion of patients who permanently discontinued treatment due …
Related search queries
PRODUCT MONOGRAPH INCLUDING PATIENT, PRODUCT MONOGRAPH . INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION, INCLUDING PATIENT, INCLUDING PATIENT MEDICATION INFORMATION, PRODUCT MONOGRAPH. INCLUDING PATIENT MEDICATION INFORMATION, INCLUDING PATIENT MEDICATION, INFORMATION, Including